3-alkenyl-GABA analogs (HMR)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name3-alkenyl-GABA analogs (HMR)
Drug Alias Name3-substituted-alkenyl-GABA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-amino-N-butyrate transaminase inhibitors
TargetsGamma-amino-N-butyrate transaminase
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoechst Marion Roussel SA (France)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoechst Marion Roussel SA (France)Marion Merrell Dow (Europe) AG
Active IndicationsN/A
Inactive IndicationsEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A